Centocor ( CNTO ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Centocor ( CNTO )

CNTO 0.00001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Thean who wrote (143)	8/14/1997 11:11:00 PM
From: FNS	of 965

Thean: In response to your Question: "Any idea on the exact timing on when this expanded indication will be up for FDA approval decision?" I recall CNTO spokesperson on CNBC indicating that ReoPro was expected to be submitted for unstable angina early in year and hopefully recommended for approval by year-end...this is purely subjective on my part...one could certainly get a transcript for clarification. On the other hand, I'm sure CNTO may have a different viewpoint at this time. I've not heard anything official. Perhaps others on this thread might comment. Certainly hope potential benefit and projected sales will make ReoPro a milestone and cost effective drug. I also look forward to news on CNTF.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next